Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...

China: Combining dapagliflozin with calorie restriction resulted in a higher rate of type 2 diabetes (T2D) remission, along ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...

Dapagliflozin alongside moderate calorie restricted diet leads to much higher rates of remission from early type 2 diabetes, ...

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

Diabetes remission was achieved in 44 and 28% of patients in the dapagliflozin and placebo groups, respectively. HealthDay News — For patients with overweight or obesity and type 2 diabetes ...